Our Methodology

The Nootropic Lab uses a 5-pillar scoring framework applied consistently to every product. No brand pays for a review or influences our scores.

5-Pillar Scoring Framework

Ingredient quality (25%)

We assess whether each ingredient has peer-reviewed human clinical trial evidence for cognitive benefits. Proprietary blends with hidden doses are penalised.

Dosing vs. clinical evidence (30%)

Dosing is the share of a product's ingredients with a reference dose on our ingredient pages whose label-stated daily amount meets that page's minimum. An amount the label hides (a share of a proprietary blend) or states on a different basis (such as a dried-herb equivalent instead of the extract) counts as not met. Ingredients with no reference page are listed but not scored.

Formula transparency (20%)

Full disclosure of all ingredient doses scores highest. "Matrix" blends or ingredients without standardisation data reduce scores.

Value for money (15%)

Price per serving (in EUR) divided by the number of clinical-dose ingredients.

Brand trust (10%)

Composite of Trustpilot score (50%), BBB/Trustpilot EU complaint volume, subscription cancellation transparency, and third-party testing documentation.

Our best-nootropics guides rank only products scoring 7.0/10 or more; the bar was 7.5 until 9 October 2026 and was set to 7.0 when the dosing pillar became computed from label doses, which lowered scores by about a point overall.

EU Rules and What We Check

Food supplements sold in the EU fall under the rules below. We keep our own copy within the EU-authorised health claims and mark which products are sold from an EU storefront; we do not verify each product's regulatory compliance, which is the seller's responsibility.

Directive 2002/46/EC — food supplement ingredient safety
Regulation (EC) 1924/2006 — only EU-authorised health claims (assessed by EFSA)
Regulation (EU) 2015/2283 — Novel Food authorisation status

The EU storefront mark is a separate label: it shows that a product is sold through a dedicated EU storefront priced in EUR, and no pillar score is adjusted for it. Pillar scores, including Value for Money, are editorial ratings recorded for each product. Not every product in our EU coverage has a euro price on record; NooCube, for example, has no EU storefront and is listed with its US-dollar price only.

Affiliate Disclosure

The Nootropic Lab earns affiliate commissions when readers purchase products through our links. This does not influence our editorial scores or rankings. All affiliate relationships are disclosed on every page where they apply.

Medical Disclaimer

Content on The Nootropic Lab is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before taking any supplement.

Editorial Standards

Beyond the 5-pillar scoring framework, every page on this site is produced under the following editorial standards. These standards apply to all 8 regional editions and govern how content is researched, reviewed, corrected, and disclosed.

1. Review protocol

Products are evaluated from manufacturer-published ingredient lists, regulatory filings, and third-party Certificates of Analysis when available. Each ingredient dose on the label is compared with the doses used in peer-reviewed clinical trials.

2. Conflict-of-interest policy

We earn affiliate commissions from links on commercial pages. Affiliate relationships do not influence:

5-pillar scores (set before any affiliate program is evaluated)
Listicle ranking position (driven by score + use-case fit only)
Pros/cons content (criticism is preserved even on affiliate-active products)
Clinical-dose audit verdicts (purely data-driven against PubMed-indexed RCTs)

We do not accept payment for reviews, sponsored content placements, or guaranteed-position promotion. Affiliate disclosures appear at the top of every commercial page, before the first call-to-action, in compliance with FTC 16 CFR Part 255 (US), ASA CAP Code (UK), and equivalent advertising codes in each region we publish.

3. Source-citation policy

Clinical-dose claims are sourced from PubMed-indexed human randomized controlled trials, meta-analyses, and Examine.com syntheses. Regulatory claims are sourced from primary regulator documents (FDA, EFSA, TGA, Health Canada, MHLW Consumer Affairs Agency, ANMAT, ANVISA, COFEPRIS, SFDA, BPOM, HSA, NPRA, JAKIM, BPJPH). When a claim cannot be sourced from primary literature or a primary regulator, it is either omitted or flagged as "limited evidence" / "manufacturer claim only". We do not cite secondary aggregators (Healthline, Verywell) as primary sources for clinical claims.

4. Correction policy

We aim to respond to substantive editorial corrections within 5 business days and to update or retract incorrect content within 10 business days of verification. When a correction is made:

The page's dateModified Article-schema field is updated to reflect the change.
For factual corrections (dose values, regulatory status, brand ownership), the prior statement is replaced and a brief note is added to the page when the correction is material to a reader's purchase decision.
We do not silently delete published claims. Significant corrections to scored comparisons trigger a re-score under the same 5-pillar framework with a visible date.

Send corrections to [email protected]. Include the page URL, the specific claim, and a primary source supporting the correct version.

5. Editorial-team identity

The Nootropic Lab operates as an independent editorial collective. We do not disclose individual contributors by name and do not feature personal brands within reviews. This is a deliberate choice: it keeps the focus on the methodology and the data, and reduces the risk that a single contributor's preferences disproportionately influence rankings. Every review applies the same 5-pillar framework documented above; consistency is the credibility signal, not authority by persona.

6. Region-specific regulatory framing

Each regional edition of this site applies the YMYL disclaimer language mandated or expected by that region's primary regulator: DSHEA (US FDA), Reg (EC) 1924/2006 + EFSA register (EU), Health Canada NPN (CA), TGA Therapeutic Goods Advertising Code (AU), PMD Act + FFC + FOSHU (JP), ANVISA / COFEPRIS / ANMAT (LATAM, with a catalogue check against the substances named in the seven products prohibited by ANMAT Disposición 2105/2022 for Argentine traffic), SFDA + Halal certification (GCC), HSA + BPOM + NPRA + Halal mandatory ID/MY (SEA). Cognitive claims that are not approved by the relevant regulator are reframed as ingredient mechanisms or consumer experience and never asserted as label-grade health claims.

Editorial contact

Editorial corrections, regulatory inquiries, partnership requests:

[email protected]

For full publisher information see our imprint.